BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed CERS catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:5d5bc46c06a1075462f8@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261215
DTEND;VALUE=DATE:20261216
SUMMARY:CERS P2 readout (est.): A Recovery and Lifespan Study Using INTERCE
 PT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With
  AS-1
DESCRIPTION:A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells P
 repared Using the INTERCEPT Blood System for RBCs With AS-1\nNCT07015437 |
  PHASE2 | RECRUITING | sponsor: Cerus Corporation\nPrimary completion date
  (ESTIMATED)\; top-line results usually follow later.\nTicker CERS (confid
 ence 0.9)\nSource: https://clinicaltrials.gov/study/NCT07015437\nSchedulin
 g/reference data from public records\; dates can move. Not investment\, le
 gal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT07015437
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
